PFA-100-measured aspirin resistance linked to CV events

PFA-100-measured aspirin resistance linked to CV events

(HealthDay)—Aspirin resistance, measured using the Platelet Function Analyzer (PFA)-100 system, is associated with cardiovascular events in aspirin-treated patients, according to a study published online Oct. 21 in the Journal of Clinical Pharmacy and Therapeutics.

H.Y. Chen, M.D., from Taipei City Hospital in Taiwan, and P. Chou, Ph.D., from the Yang-Ming University School of Medicine in Taiwan, assessed resistance in 465 aspirin-treated patients from the outpatient department. Patients were followed for five years for hospitalization for any acute cardiovascular event.

The researchers found that 20 percent of the patients had aspirin resistance. There was a strong correlation for prior hospitalization history of with aspirin resistance (P = 0.001). Cardiovascular events had developed in 11 patients with aspirin resistance (eight stroke and three ) and in nine patients without aspirin resistance (four stroke and five myocardial infarction) at the five-year follow-up (12.1 versus 2.4 percent; P < 0.001). A strong correlation was seen between aspirin resistance and cardiovascular events at the five-year follow-up in multivariate analysis (adjusted odds ratio, 4.28; 95 percent confidence interval, 1.64 to 11.2; P = 0.03).

"We posit that measuring aspirin by PFA-100 may play a role in clinical cardiovascular prevention," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

Copyright © 2017 HealthDay. All rights reserved.

Citation: PFA-100-measured aspirin resistance linked to CV events (2017, October 31) retrieved 3 March 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Quitting daily aspirin therapy may increase second heart attack, stroke risk


Feedback to editors